The Board of Directors of METabolic EXplorer has five members, appointed by the General Meeting of Shareholders. The Chairman is Benjamin Gonzalez (see Organisation), three other members independent and two others members non-independant :
Board of Directors
After an engineering degree from ESCOM (Higher School of Organic and Mineral Chemistry), Anne Abriat-Hemmendinger worked 25 years for the L'Oréal group in R&D and then in Marketing Innovation for beauty industry products development, for international vocation brands. She also worked for Coty at the Center of Excellence in Geneva, where she led numerous innovation projects. In 2017, she founded The Smell & Taste Lab, a consulting company specializing in innovation and marketing for cosmetics, nutrition and well-being. She assists companies at the operational and strategic level in the Beauty and Health sectors, all along the value chain. From 2012 to 2018 she was an independent director for Naturex which was acquired by Givaudan. She joined METabolic EXplorer's Board of Directors in 2019 and is also a member of the company's Strategy Committee and of the Audit Committee.
Daniel Chéron holds a degree in economic sciences from the Université d’Orléans (France). In 1976, he joined Limagrain, an international cooperative group specialised in seeds and grain products, and has spent most of his professional career there. After holding various operational positions, he was appointed Chief Executive Officer of Groupe Limagrain and Coopérative Agricole Limagrain. Mr Chéron was in charge of devising and implementing strategy and oversaw and led the Group's boards of directors (including that of a publicly listed holding company). Since joining the METabolic EXplorer Board of Directors in 2015, Mr Chéron has provided expertise in agro-industry and the diversity of agricultural resources. He is also chairman of the company's strategy committee and of the Remuneration and Appointments Committee.
Jérôme Dupas holds an engineering degree from the Université de Technologie de Compiègne and an MBA from ESSEC business school. He has extensive experience in investment banking in Paris and London. After serving as Managing Director of HSBC Investment Bank in Paris, he was head of Corporate Finance at Fortis and then at BNP Paribas Fortis in France. He is currently Managing Director of Corporate Finance at Pramex International, a subsidiary of the BPCE group. Mr Dupas has participated in the governance of METabolic EXplorer since 2009 and is president of its Audit Committee.
Magali Joëssel (Bpifrance Investment Representative)
Previously in charge of the General Interest Investments Department of Caisse des Dépôts then of the Strategy Department of Bpifrance, Magali Joëssel is now Director of the SPI fund (Société de Projets Industriels) fund. The SPI fund is endowed with € 800 million from the State, through the Programme d’Investissement d’Avenir (PIA) and the European Investment Bank (EIB). It was created with the objective of investing in the industrialization of innovative projects, very often carrying technologies that are unique in Europe, or even at the global level, respectful of the environment, creators of jobs and established in the territories. Magali Joessel, as representative of the SPI fund, is a member of the Group's Strategy Committee.
A Senior Investment Director at Bpifrance's SPI investment fund, Jean-Philippe Richard is on the boards of several small and midsize industrial companies in Europe operating in the bioproduction and New Space sectors. With more than 25 years of experience in investment banking, strategy consulting, and general management, he has in-depth knowledge of the bioproduction and biotechnology sectors in Europe and brings proven and unique expertise in the industrial application of innovation, notably in the field of green chemistry. Jean-Philippe Richard is a member of the Audit Committee and a member of the Remuneration and appointments committee of METEX.
The Board of Directors has created three special committees to serve as supervisory bodies and appointed a censor of the board .
The Strategy Committee examines the company's strategic priorities, reviews information concerning market trends and the competition, and assesses medium- and long-term prospects based on these analyses. It studies any development plans of the company and in particular major investments and proposed industrial partnerships. It is made up of all the members of the board of directors.
The Audit Committee examines the financial statements submitted by the independent auditors and ensures that the accounting methods used to prepare the consolidated and company financial statements are relevant and consistent. The Audit Committee has three members: Jérome Dupas (chairman), Anne Abriat and Jean-Philippe Richard.
Remuneration and Appointments Committee
The Remuneration and Appointments Committee makes recommendations to the Board of Directors concerning the appointment of Board members, the Chairman of the Board, and the members of its committees. It also recommends the remuneration to be paid to the corporate officers. This committee has two members: Daniel Cheron (chairman) and Jean-Philippe Richard.
After a 36-year career in the Royal Dutch Shell group, where he held positions in production, sales, marketing and business development and was also in charge of technologies, with national and international responsibilities, Hans Vogelsang served as member of the Board of Directors of METabolic EXplorer from 2008 to 2017. He has also held operational management positions and served on boards of directors in the sectors of petrochemicals, industrial engineering, and industrial services. In 2001 and 2002, he was President of Technology at Basell Polyolefins, and from 2003 to 2013, Senior Independent Non-Executive Director at Bodycote International plc. (LES : BOY). From 2003 to 2006, he was also an advisor for British Sugar. In 2017, Hans Vogelsang has been appointed Censor of the Board of the company.